Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: Negative Results, Disorders of the Nervous System

CRPS Is Not Associated with Altered Sensorimotor Cortex GABA or Glutamate

Barbara Lee, Luke A. Henderson, Caroline D. Rae and Flavia Di Pietro
eNeuro 24 January 2020, 7 (1) ENEURO.0389-19.2020; DOI: https://doi.org/10.1523/ENEURO.0389-19.2020
Barbara Lee
1Department of Anatomy and Histology, Brain and Mind Centre, University of Sydney, Sydney 2006, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara Lee
Luke A. Henderson
1Department of Anatomy and Histology, Brain and Mind Centre, University of Sydney, Sydney 2006, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luke A. Henderson
Caroline D. Rae
2Neuroscience Research Australia, Sydney 2031, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flavia Di Pietro
1Department of Anatomy and Histology, Brain and Mind Centre, University of Sydney, Sydney 2006, Australia
3School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Perth 6102, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Flavia Di Pietro
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    A, A psychometric function of two-point discrimination threshold for a single subject’s index finger. The percentage of two-point perception was plotted against the different point-to-point distances tested in the two-point discrimination task. The gray curve with gray squares indicates the subject’s percentage of correct responses for each distance, and the black curve with circles is the fitted binary logistic regression. The two-point discrimination threshold is the distance at which correct two-point perception was at 50% (black arrow). B, MRS voxel placement on the sensorimotor cortex. Voxel placement over the left sensorimotor cortex of a single subject indicated by the white square outline. The voxel was guided by the “hand hook” in the sagittal plane and the "hand knob" in the axial plane. C, A typical MEGA-PRESS spectrum obtained from the sensorimotor cortex. NAA, N-acetyl aspartate. D, Plots demonstrating the age distribution of the two groups. The left plot shows subjects used for GABA, the middle plot for Glx, and the right plot for TPD. While there were significant differences between groups if all control and CRPS subjects were used for the analyses, restriction of the control group numbers allowed for group comparisons in which there was no overall significant difference in age (Mann–Whitney U test, p > 0.05), sex (χ2 test, p > 0.05), or handedness (Mann–Whitney U test, p > 0.05).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Plots of GABA/Cr ratios (×10−1) of a 30 × 30 × 30 mm voxel placed over the hand representation of the sensorimotor cortex. A, Values for individual subjects with upper limb CRPS for the right and left, dominant and nondominant hemispheres and also for the affected (hemisphere representing the side of ongoing pain) and unaffected hemispheres. Plots show pairwise connections for each individual subject. B, Values for individual control subjects. C, Values comparing individual CRPS and control subjects. Horizontal lines indicate the mean ± SEM for each group. Note there are no significant differences between any hemisphere in the CRPS or control subjects alone or between CRPS and control groups.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Plots of Glx/Cr ratios (×10−1) of a 30 × 30 × 30mm voxel placed over the hand representation of the sensorimotor cortex. A, Values for individual subjects with upper limb CRPS for the right and left hands, dominant and nondominant hemispheres, and also for the affected (hemisphere representing the side of ongoing pain) and unaffected hemispheres. Plots show pairwise connections for each individual subject. B, Values for individual control subjects. C, Values comparing individual CRPS subject and control subject groups. Horizontal lines indicate the mean ± SEM for each group. Note that there are no significant differences between any hemisphere in the CRPS or control subjects alone or between CRPS and control groups.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Plots of TPD in millimeters. A, Values for individual subjects with upper limb CRPS for the right and left hands, dominant and nondominant hands, and also for the affected (hand with ongoing pain) and unaffected hands. Plots show pairwise connections for each individual subject. B, Values for individual control subjects. C, Values comparing individual CRPS subject and control subject groups. Horizontal lines indicate the mean ± SEM for each group. Note that CRPS subjects displayed reduced tactile acuity (increased TPD) in the affected hand compared with the unaffected hand and the dominant and nondominant hands in control subjects (*p < 0.05).

Tables

  • Figures
    • View popup
    Table 1

    Demographics and clinical characteristics of patients with CRPS

             Signs (symptoms)  
    SubjectAgeSexEHI score (handedness)Pain duration
    (years) 
    CRPS affected regionInciting eventMedicationsComorbiditySensoryVaso-motorSudomotor/edemaMotor/trophicPain intensity (diary VAS)Pain intensity (day VAS)
    149M100.0 (R)7.0 R UL,
    R LL,
    L LL, face, abdomen
    Pain in R handTurmeric tabletsNone+ (+)+ (+)+ (+)+ (+)4.54.0
    256F100.0 (R)4.2 L UL,
    R UL,
    R LL,
    R and L chest
    L humerus fractureDuloxetine, gabapentin, oxycodone, quetiapine, tapentadolL radial nerve palsy, Triangular fibrocartilage complex of R hand+ (+)+ (+)+ (+)+ (+)8.17.8
    356F60.0 (R)0.9 R UL,
    R neck,
    R chest
    Spontaneous onsetAshwagandha, budesonide, cannabis, codeine, formoterol, oxycodone, paracetamol, salbutamolBack pain, COPD, fibromyalgia, osteoarthritis, peptic ulcer, radiculopathy, Raynaud’s disease, spinal disc herniation+ (+)+ (+)− (+)+ (+)8.37.9
    462F100.0 (R)6.2 L UL,
    R UL 2
    R hand tendon release surgery Amitriptyline, cannabidiol drops, codeine , levothyroxine, magnesium, paracetamol, topiramate, tramadol, valerianDiverticulitis, gastroesophageal reflux disease, Graves’ disease (thyroidectomized)+ (+)+ (+)− (+)+ (+)5.84.3
    558F−20.0 (A)8.7 R UL,
    R LL,
    R face
    R arm surgery Codeine, duloxetine, linagliptin, meloxicam, metformin, paracetamol Diabetes+ (+)+ (+)+ (+)+ (+)4.74.1
    667F100.0 (R)9.5 R UL,
    L UL,
    R LL,
    L LL
    R radius fracture Amlodipine, gabapentin, ketamine in lipoderm cream, metformin, metoprolol, pantoprazole, salbutamol Asthma, diabetes, gastric reflux, hypertension, osteoarthritis, pubic symphysitis, supraventricular tachycardia+ (+)− (+)− (+)+ (+)3.75.0
    747M44.4 (R)1.5 R UL Spontaneous onset Amlodipine, atorvastatin, ibuprofen, paracetamol, perindopril, pregabalin Hyperlipidemia, hypertension+ (+)+ (+)− (−)+ (+)6.87.1
    834F−23.1 (A)5.3 R UL,
    R LL,
    R hip
    R wrist fracture Amitriptyline, buprenorphine patch Migraine, R hip bursitis+ (+)+ (+)+ (+)+ (+)4.32.4
    926F−40.0 (A)1.3 R UL,
    L and R neck,
    spine,
    L LL
    R hand nerve damageNoneEndometriosis, polycystic ovarian syndrome+ (+)+ (+)+ (+)+ (+)5.46.8
    1046F80.0 (R)3.9 L UL L hand carpal tunnel release surgery Amitriptyline, betahistine, duloxetine, naproxen, pantoprazole, rizatriptan, tapentadol, valaciclovir Carpal tunnel of R hand, fibromyalgia, herpes, migraine, polycystic ovarian syndrome with insulin resistance, vertigo+ (−)+ (+)+ (+)− (+)0.65.6
    1124F70.0 (R)2.6 R UL,
    L UL
    Overload Amitriptyline, gabapentin, levothyroxine Hashimoto’s disease− (−)− (+)+ (+)+ (+)4.54.4
    1252F40.0 (A)2.9 R UL,
    R torso
    Broke tailbone Ashwagandha, fish oil, ibuprofen, magnesium, mega B, melatonin, paracetamol, tapentadol, vitamin C, vitamin D Endometriosis+ (+)+ (+)− (+)− (+)3.83.5
    1338F17.6 (A)12.7 R UL,
    R neck,
    L LL
    Spontaneous onset Duloxetine, gabapentin, naloxone, oxycodone, palmitoylethanolamide (PEA) Endometriosis, endosalpingiosis, Raynaud’s disease+ (+)+ (+)+ (+)+ (+)0.05.9
    1452M−88.9 (L)1.9 R UL,
    L and R neck, back
    R scaphoid fusion surgery Cholecalciferol, ibuprofen, magnesium, oxycodone, paracetamol, pregabalin, tramadol, venlafaxine, zopiclone L shoulder bursitis, Sleep apnea+ (+)+ (+)+ (+)+ (+)7.07.6
    • R, Right; L, left; A, ambidextrous; UL, upper limb; LL, lower limb; +, present; −, absent. Bold type indicates the CRPS region with the most severe pain. Italic type indicates remission of the CRPS region. Underline indicates medication taken in the last 24 h of the day of testing. The presence (+) or absence (-) of CRPS signs and symptoms are presented as signs (symptoms).

Back to top

In this issue

eneuro: 7 (1)
eNeuro
Vol. 7, Issue 1
January/February 2020
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CRPS Is Not Associated with Altered Sensorimotor Cortex GABA or Glutamate
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
CRPS Is Not Associated with Altered Sensorimotor Cortex GABA or Glutamate
Barbara Lee, Luke A. Henderson, Caroline D. Rae, Flavia Di Pietro
eNeuro 24 January 2020, 7 (1) ENEURO.0389-19.2020; DOI: 10.1523/ENEURO.0389-19.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
CRPS Is Not Associated with Altered Sensorimotor Cortex GABA or Glutamate
Barbara Lee, Luke A. Henderson, Caroline D. Rae, Flavia Di Pietro
eNeuro 24 January 2020, 7 (1) ENEURO.0389-19.2020; DOI: 10.1523/ENEURO.0389-19.2020
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • chronic pain
  • cortical reorganization
  • GABA
  • glutamate
  • inhibition
  • sensorimotor cortex

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: Negative Results

  • The Atoh1-Cre Knock-In Allele Ectopically Labels a Subpopulation of Amacrine Cells and Bipolar Cells in Mouse Retina
  • Axonal Transport of Lysosomes Is Unaffected in Glucocerebrosidase-Inhibited iPSC-Derived Forebrain Neurons
  • Chronic Visual Stimulation with LED Light Flickering at 24, 40, or 80 Hz Failed to Reduce Amyloid β Load in the 5XFAD Alzheimer’s Disease Mouse Model
Show more Research Article: Negative Results

Disorders of the Nervous System

  • Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice
  • Elevated Serotonin in Mouse Spinal Dorsal Horn Is Pronociceptive
  • Tug-of-peace: Visual Rivalry and Atypical Visual Motion Processing in MECP2 duplication Syndrome of Autism
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.